BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 19629135)

  • 1. The c-MYC-interacting proapoptotic tumor suppressor BIN1 is a transcriptional target for E2F1 in response to DNA damage.
    Cassimere EK; Pyndiah S; Sakamuro D
    Cell Death Differ; 2009 Dec; 16(12):1641-53. PubMed ID: 19629135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism.
    Kinney EL; Tanida S; Rodrigue AA; Johnson JK; Tompkins VS; Sakamuro D
    J Cell Physiol; 2008 Sep; 216(3):621-31. PubMed ID: 18348166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of E2F1-induced apoptosis by poly(ADP-ribosyl)ation.
    Kumari A; Iwasaki T; Pyndiah S; Cassimere EK; Palani CD; Sakamuro D
    Cell Death Differ; 2015 Feb; 22(2):311-22. PubMed ID: 25257171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of the tumor suppressor BIN1 enables ATM Ser/Thr kinase activation by the nuclear protein E2F1 and renders cancer cells resistant to cisplatin.
    Folk WP; Kumari A; Iwasaki T; Pyndiah S; Johnson JC; Cassimere EK; Abdulovic-Cui AL; Sakamuro D
    J Biol Chem; 2019 Apr; 294(14):5700-5719. PubMed ID: 30733337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-MYC suppresses BIN1 to release poly(ADP-ribose) polymerase 1: a mechanism by which cancer cells acquire cisplatin resistance.
    Pyndiah S; Tanida S; Ahmed KM; Cassimere EK; Choe C; Sakamuro D
    Sci Signal; 2011 Mar; 4(166):ra19. PubMed ID: 21447800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MCPH1/BRIT1 cooperates with E2F1 in the activation of checkpoint, DNA repair and apoptosis.
    Yang SZ; Lin FT; Lin WC
    EMBO Rep; 2008 Sep; 9(9):907-15. PubMed ID: 18660752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The c-Myc-interacting adaptor protein Bin1 activates a caspase-independent cell death program.
    Elliott K; Ge K; Du W; Prendergast GC
    Oncogene; 2000 Sep; 19(41):4669-84. PubMed ID: 11032017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NEDDylation controls the target specificity of E2F1 and apoptosis induction.
    Aoki I; Higuchi M; Gotoh Y
    Oncogene; 2013 Aug; 32(34):3954-64. PubMed ID: 23001041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bin1 functionally interacts with Myc and inhibits cell proliferation via multiple mechanisms.
    Elliott K; Sakamuro D; Basu A; Du W; Wunner W; Staller P; Gaubatz S; Zhang H; Prochownik E; Eilers M; Prendergast GC
    Oncogene; 1999 Jun; 18(24):3564-73. PubMed ID: 10380878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E2F1 confers anticancer drug resistance by targeting ABC transporter family members and Bcl-2 via the p73/DNp73-miR-205 circuitry.
    Alla V; Kowtharapu BS; Engelmann D; Emmrich S; Schmitz U; Steder M; PĆ¼tzer BM
    Cell Cycle; 2012 Aug; 11(16):3067-78. PubMed ID: 22871739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse double minute antagonist Nutlin-3a enhances chemotherapy-induced apoptosis in cancer cells with mutant p53 by activating E2F1.
    Ambrosini G; Sambol EB; Carvajal D; Vassilev LT; Singer S; Schwartz GK
    Oncogene; 2007 May; 26(24):3473-81. PubMed ID: 17146434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential regulation of E2F1 apoptotic target genes in response to DNA damage.
    Pediconi N; Ianari A; Costanzo A; Belloni L; Gallo R; Cimino L; Porcellini A; Screpanti I; Balsano C; Alesse E; Gulino A; Levrero M
    Nat Cell Biol; 2003 Jun; 5(6):552-8. PubMed ID: 12766778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E2F1 and c-Myc in cell growth and death.
    Matsumura I; Tanaka H; Kanakura Y
    Cell Cycle; 2003; 2(4):333-8. PubMed ID: 12851485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA damage induces transcriptional activation of p73 by removing C-EBPalpha repression on E2F1.
    Marabese M; Vikhanskaya F; Rainelli C; Sakai T; Broggini M
    Nucleic Acids Res; 2003 Nov; 31(22):6624-32. PubMed ID: 14602923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor suppressor TAp73 gene specifically responds to deregulated E2F activity in human normal fibroblasts.
    Ozono E; Komori H; Iwanaga R; Tanaka T; Sakae T; Kitamura H; Yamaoka S; Ohtani K
    Genes Cells; 2012 Aug; 17(8):660-72. PubMed ID: 22702391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yin Yang 1 induces transcriptional activity of p73 through cooperation with E2F1.
    Wu S; Murai S; Kataoka K; Miyagishi M
    Biochem Biophys Res Commun; 2008 Jan; 365(1):75-81. PubMed ID: 17980704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. hSirT1-dependent regulation of the PCAF-E2F1-p73 apoptotic pathway in response to DNA damage.
    Pediconi N; Guerrieri F; Vossio S; Bruno T; Belloni L; Schinzari V; Scisciani C; Fanciulli M; Levrero M
    Mol Cell Biol; 2009 Apr; 29(8):1989-98. PubMed ID: 19188449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A structure-based model of the c-Myc/Bin1 protein interaction shows alternative splicing of Bin1 and c-Myc phosphorylation are key binding determinants.
    Pineda-Lucena A; Ho CS; Mao DY; Sheng Y; Laister RC; Muhandiram R; Lu Y; Seet BT; Katz S; Szyperski T; Penn LZ; Arrowsmith CH
    J Mol Biol; 2005 Aug; 351(1):182-94. PubMed ID: 15992821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of E2F1-induced apoptosis by the nucleolar protein RRP1B.
    Paik JC; Wang B; Liu K; Lue JK; Lin WC
    J Biol Chem; 2010 Feb; 285(9):6348-63. PubMed ID: 20040599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The proapoptotic gene SIVA is a direct transcriptional target for the tumor suppressors p53 and E2F1.
    Fortin A; MacLaurin JG; Arbour N; Cregan SP; Kushwaha N; Callaghan SM; Park DS; Albert PR; Slack RS
    J Biol Chem; 2004 Jul; 279(27):28706-14. PubMed ID: 15105421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.